The Use of Personalized Medicine in Pancreatic Ductal Adenocarcinoma (PDAC): New Therapeutic Opportunities

The Use of Personalized Medicine in Pancreatic Ductal Adenocarcinoma (PDAC): New Therapeutic Opportunities

Pancreatic cancer constitutes a significant cause of cancer-related fatalities, with a five-year survival rate of only 12%. The most prevalent form of this disease is pancreatic ductal adenocarcinoma (PDAC). Given that a single therapeutic intervention has proven inadequate for the treatment of PDAC...

Full description

Saved in:

Bibliographic Details
Main Authors:	Inês Mendes, Nuno Vale
Format:	Article
Language:	English
Published:	MDPI AG 2024-12-01
Series:	Future Pharmacology
Subjects:	genetics epigenetics microbiome-acquired resistance personalized medicine
Online Access:	https://www.mdpi.com/2673-9879/4/4/49
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Realising the therapeutic potential of the human microbiota in metastatic pancreatic ductal adenocarcinoma
by: James M. Halle-Smith, et al.
Published: (2023-12-01)

Neurotensin is a Versatile Modulator of In Vitro Human Pancreatic Ductal Adenocarcinoma Cell (PDAC) Migration
by: Tatjana Mijatovic, et al.
Published: (2007-01-01)

Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell‐free RNA
by: Martin Metzenmacher, et al.
Published: (2025-02-01)

Calling the question: what is mammalian transgenerational epigenetic inheritance?
by: Hasan Khatib, et al.
Published: (2024-12-01)

Niraparib perturbs autophagosome-lysosome fusion in pancreatic ductal adenocarcinoma and exhibits anticancer potential against gemcitabine-resistant PDAC
by: Zehui Yao, et al.
Published: (2025-01-01)

Microbiome and metabolome analysis in smoking and non-smoking pancreatic ductal adenocarcinoma patients
by: Xiao Liang, et al.
Published: (2024-12-01)

Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
by: Shivan Sivakumar, et al.
Published: (2025-02-01)

Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
by: Daniel Oyon, et al.
Published: (2025-01-01)

Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study
by: Neil Daniel, et al.
Published: (2024-10-01)

Epigenetic Activation of the CMTM6‐IGF2BP1‐EP300 Positive Feedback Loop Drives Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
by: Ying‐Qin Zhu, et al.
Published: (2024-12-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
by: John G. Yuen, et al.
Published: (2024-03-01)

Challenges and Opportunities in Managing Geriatric Depression: The Role of Personalized Medicine and Age-Appropriate Therapeutic Approaches
by: Agnieszka Jaros, et al.
Published: (2024-10-01)

Nongenetic evolution of the tumor: from challenges to new therapeutic opportunities
by: Elisa Oricchio
Published: (2025-01-01)

Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma
by: Peiyi Liu, et al.
Published: (2024-11-01)

Diagnosis of Pancreatic Ductal Adenocarcinoma Using Deep Learning
by: Fulya Kavak, et al.
Published: (2024-10-01)

Genetic confounds of transgenerational epigenetic inheritance in mice
by: Daniel M. Sapozhnikov, et al.
Published: (2024-12-01)

Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis
by: Yue Gao, et al.
Published: (2024-12-01)

The Applicable Law on Personal Status of Refugees: A Comparative Analysis of Iranian Law and the 1951 Refugee Convention
by: Hossein KAVIAR, et al.
Published: (2024-11-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

Epigenetic profiling for prognostic stratification and personalized therapy in breast cancer
by: Xiao Guo, et al.
Published: (2025-01-01)

Assessing the diagnostic potential of SATB2 and β-catenin as biomarkers and therapeutic targets in pancreatic ductal adenocarcinoma
by: Noha Said Helal, et al.
Published: (2025-01-01)

Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
by: Caroline Y. K. Fong, et al.
Published: (2019-01-01)

Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
by: Heng‐Chung Kung, et al.
Published: (2023-04-01)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
by: Florian Gebauer, et al.
Published: (2017-01-01)

Ferroptosis in Cancer: Epigenetic Control and Therapeutic Opportunities
by: Roberta Veglia Tranchese, et al.
Published: (2024-11-01)

Interactions between extracellular vesicles and microbiome in human diseases: New therapeutic opportunities
by: Rongjin Luo, et al.
Published: (2023-05-01)

Psychological Adjustment to Acquired Facial Disfigurement: personality characteristics, self-concept and satisfaction with Social Support - a longitudinal study
by: J. Mendes, et al.
Published: (2019-09-01)

Critical review of aging clocks and factors that may influence the pace of aging
by: Mildred Min, et al.
Published: (2024-12-01)

miR-210 Mediated Hypoxic Responses in Pancreatic Ductal Adenocarcinoma
by: Maria Mortoglou, et al.
Published: (2024-11-01)

Epigenetic modifications and emerging therapeutic targets in cardiovascular aging and diseases
by: Yurou Qiu, et al.
Published: (2025-01-01)

New insights into methods to measure biological age: a literature review
by: Aanchal Mathur, et al.
Published: (2024-12-01)

The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and aging
by: Giulia Matacchione, et al.
Published: (2024-11-01)

FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival
by: Nathalie B. Rasko, et al.
Published: (2025-01-01)

A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma
by: Vlad Herlea, et al.
Published: (2020-01-01)

Nuclear Position and Shape Deformation of Chromosome 8 Territories in Pancreatic Ductal Adenocarcinoma
by: Sylvia Timme, et al.
Published: (2011-01-01)

Identification of key regulators in pancreatic ductal adenocarcinoma using network theoretical approach.
by: Kankana Bhattacharjee, et al.
Published: (2025-01-01)

Signatures of lower respiratory tract microbiome in children with severe community-acquired pneumonia using shotgun metagenomic sequencing
by: Ting-Yu Yen, et al.
Published: (2025-02-01)

Gut Microbiome Alteration in HIV/AIDS and the Role of Antiretroviral Therapy—A Scoping Review
by: Zsófia Gáspár, et al.
Published: (2024-11-01)

Precision Medicine in Anesthesia: Pharmacogenomics and Personalized Care
by: Amit Kumar Malviya, et al.
Published: (2024-11-01)